Berkshire Put Bending Spoons On My Radar

Bending Spoons has paid approximately $10B for its portfolio, including the announced—but not yet closed—Miro acquisition, with half of that spending occurring this year. Reported revenue growth is being driven by acquisitions; organic growth was 3% in Q2, while revenue per Spooner more than doubled over two years. The article’s author assigns the company a buy rating.

Analysis

The key underwriting question is whether Bending Spoons is compounding product value or assembling reported growth through acquisitions and operating cuts. Low single-digit organic growth makes the acquisition engine—not the portfolio’s underlying demand—the near-term growth driver. That raises sensitivity to purchase multiples, financing terms, integration capacity and the availability of further targets. Revenue per employee more than doubling is an efficiency signal, but not proof of durable product improvement: it can also reflect headcount reductions or price increases that risk customer churn and weaker product development.

Over the next 1–3 months, verify the Miro transaction’s closing conditions, funding mix and post-close operating plan; these determine dilution, balance-sheet exposure and execution risk. Over 6–18 months, track organic growth, retention and product investment across acquired businesses. A slowdown in deal flow would expose the modest organic-growth base, while aggressive cost extraction could eventually impair retention and renewals. The contrarian risk is that investors reward headline scale and efficiency before evidence of durable organic growth; the counterpoint is that disciplined integration could make the portfolio more productive than standalone ownership. No valuation, leverage or deal-level economics are provided, so the positive sentiment alone is not enough to establish attractive risk/reward.

Key Decisions for Investors

• Do not chase BSP solely on acquisition-led revenue growth. Before initiating a position, verify valuation, net debt and liquidity, acquisition funding terms, and whether reported organic growth is comparable across periods and portfolio scope.
• Treat Miro close and subsequent disclosures as the near-term catalyst: reassess if financing is materially more dilutive or leverage-heavy than expected, or if management provides no measurable integration and retention milestones.
• Watch quarterly organic growth, customer retention/renewals, and product investment alongside revenue per employee. A sustained improvement in organic growth without deterioration in retention would support the compounding thesis; flat or weakening organic growth with rising efficiency metrics would argue that cost extraction is masking product risk.
• No pair or options trade is justified from the supplied information alone. A negative thesis would strengthen if deal flow slows while organic growth remains weak, or if post-acquisition retention deteriorates; it would be falsified by sustained organic acceleration and evidence that efficiency gains coexist with stable customer outcomes.